Registration of securities, business combinations

Stockholders??? Deficit (Tables)

v3.25.2
Stockholders’ Deficit (Tables)
12 Months Ended
Jul. 02, 2025
Sep. 30, 2024
Sonnet BioTherapeutics Holdings, Inc. [Member]    
Subsidiary or Equity Method Investee [Line Items]    
Schedule of Warrants Outstanding

As of June 30, 2025, the following equity-classified warrants and related terms were outstanding:

 

    Warrants Outstanding     Exercise Price     Expiration Date  
Common stock warrants August 2021     14,031     $ 2,094.4000       August 24, 2026  
Underwriter warrants August 2021     284     $ 2,618.0000       August 19, 2026  
Chanticleer warrants     6    

 

$144,144.00 - $224,224.00       April 30, 2027 - December 17, 2028  
Series C warrants     2,297     $ 7,860.1600       October 16, 2025  
Series 3 warrants     1,566     $ 717.0240       August 15, 2027  
Common stock warrants February 2023     31,563     $ 190.0800       February 10, 2028  
Underwriter warrants February 2023     1,933     $ 237.6000       February 8, 2028  
Common stock private placement warrants June 2023     28,409     $ 12.4000       June 21, 2029  
Placement agent warrants June 2023     852     $ 118.7824       December 30, 2026  
Common stock warrants October 2023     354,994     $ 9.6000       October 27, 2028  
Pre-funded warrants October 2023     99,687     $ 0.0008        
Underwriter warrants October 2023     10,664     $ 16.0000       October 24, 2028  
Placement agent warrants June 2024     14,142     $ 14.8800       June 19, 2029  
Common stock warrants June 2024     703,125     $ 12.4000       June 21, 2029  
Common stock warrants November 2024     2,222,222     $ 4.5000       November 7, 2029  
Common stock registered direct warrants December 2024     1,085,325     $ 2.1000       December 9, 2029  
Common stock PIPE warrants December 2024     673,000     $ 2.1000       December 9, 2029  
Pre-funded warrants December 2024     545,500     $ 0.0001        
Total     5,789,600                  

As of September 30, 2024, the following equity-classified warrants and related terms were outstanding:

 

    Warrants Outstanding     Exercise Price     Expiration Date
Common stock warrants August 2021     14,031     $ 2,094.40     August 24, 2026
Underwriter warrants August 2021     284     $ 2,618     August 19, 2026
Chanticleer warrants     6     $ 144,144.00 - $224,224.00     April 30, 2027 - December 17, 2028
Series C warrants     2,297     $ 7,860.16     October 16, 2025
Series 3 warrants     1,566     $ 717.024     August 15, 2027
Common stock warrants February 2023     33,982     $ 190.08     February 10, 2028
Underwriter warrants February 2023     1,933     $ 237.60     February 8, 2028
Common stock private placement warrants June 2023     28,409     $ 12.4000     June 21, 2029
Placement agent warrants June 2023     852     $ 118.7824     December 30, 2026
Common stock warrants October 2023     354,994     $ 9.6000     October 27, 2028
Pre-funded warrants October 2023     99,687     $ 0.0008    
Underwriter warrants October 2023     10,664     $ 16.0000     October 24, 2028
Placement agent warrants June 2024     14,142     $ 14.8800     June 19, 2029
Common stock warrants June 2024     703,125     $ 12.4000     June 21, 2029
Total     1,265,972